Status:

UNKNOWN

A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia

Lead Sponsor:

Martin-Luther-Universität Halle-Wittenberg

Collaborating Sponsors:

Heidelberg University

Conditions:

Schizophrenia

Schizophreniform Disorder

Eligibility:

All Genders

18-65 years

Brief Summary

Environmental risk factors for the development of schizophrenia include infections during the perinatal period or later in life with Toxoplasma gondii (TG) being one of the candidate agents. A recent ...

Eligibility Criteria

Inclusion

  • Key inclusion criteria will be a first episode of schizophrenia, schizoaffective or schizophreniform disorder.

Exclusion

  • Exclusion criteria will be major organic and substance induced disorders, refusal or withdrawal of IC.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2011

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT00686400

Start Date

May 1 2008

End Date

May 1 2011

Last Update

January 25 2010

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Dpt. of Psychiatry, University of Frankfurt

Frankfurt am Main, Germany, 60528

2

Dept. of Psychiatry, University of Halle (Saale)

Halle, Germany, 06112

3

Dept. of Psychiatry, University of Heidelberg

Heidelberg, Germany, 69115

A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia | DecenTrialz